From: Impact of a VAP bundle in Belgian intensive care units
Characteristics of patients | |||||||
---|---|---|---|---|---|---|---|
2010 | 2011 | 2013 | 2014 | 2015 | 2016 | p value | |
Number | 129 | 293 | 288 | 265 | 271 | 158 | |
Age median (IQR) | 67 (54–78) | 65 (54–75) | 66 (54–75) | 67 (57–76) | 64 (54–76) | 64 (50–71) | 0.8412 |
Sex (male) | 88 (68.8%) | 183 (62.5%) | 183 (63.5%) | 162 (61.1%) | 170 (62.7%) | 102 (64.6%) | 0.8326 |
Pre-ICU hosp. stay | 0 (0–4) | 0 (0–2) | 0 (0–2) | 1 (0–5) | 0 (0–2) | 0 (0–2) | 0.3229 |
ICU stay median | 10 (4–19) | 13 (7–21) | 8 (3–18) | 7 (2–16) | 7 (2–16) | 8 (2–19) | < 0.0001 |
Duration of ventilation median | 10.5 (4–17) | 13 (7–21) | 7 (3–16) | 5 (2–14) | 5 (1–15) | 6 (2–14) | < 0.0001 |
Type of patients | 0.0655 | ||||||
Medical | 71 (55.8%) | 156 (53.2%) | 155 (53.2%) | 138 (52.1%) | 153 (56.5%) | 94 (59.4%) | |
Scheduled surgery | 12 (9.3%) | 51 (17.4%) | 57 (19.8%) | 52 (19.6%) | 45 (16.6%) | 18 (11.4%) | |
Nonscheduled surgery | 32 (24.8%) | 51 (17.4%) | 48 (16.7%) | 59 (22.3%) | 42 (15.5%) | 30 (19%) | |
Trauma | 13 (10.1%) | 35 (16.1%) | 28 (9.7%) | 16 (6%) | 31 (11.4%) | 16 (10.1%) | |
Underlying disease | 0.2724 | ||||||
Smoker | 44 (34.1%) | 102 (47%) | 103 (35.7% | 75 (28.3%) | 81 (29.9%) | 51 (32.3%) | |
Asthma | 7 (5.4%) | 13 (4.4%) | 5 (1.7%) | 19 (7.2%) | 9(3.3%) | 5 (3.2%) | |
COPD | 36 (27.9%) | 83 (28.3%) | 89 (30.9%) | 63 (23.8%) | 64 (23.6%) | 38 (24%) | |
Solid cancer | 4 (3.1%) | 36 (12.3%) | 28 (9.7%) | 28 (10.6%) | 20 (7.4%) | 12 (7.6%) | |
Hematological cancer | 7 (5.4%) | 7 (2.4%) | 10 (3.5%) | 4 (1.5%) | 9 (3.3%) | 4 (2.5%) | |
Immunosuppression | 12 (9.3%) | 25 (8.5%) | 20 (6.9%) | 19 (7.2%) | 16 (5.9%) | 6 (3.8%) | |
Corticotherapy | 9 (7%) | 37 (12.6%) | 28 (9.7%) | 39 (14.7%) | 27 (10%) | 15 (9.5%) | |
Diabetes | 13 (10.1%) | 38 (13%) | 42 (14.6%) | 34 (12.8%) | 34 (12.5%) | 17 (10.8%) | |
Other | NA | NA | NA | 26 (9.8%) | 26 (9.6%) | 75 (47.4%) | |
Cause of ventilation | 0.0012 | ||||||
Hypoxia | 50 (38.8%) | 79 (27%) | 95 (33%) | 83 (31.3%) | 80 (29.5%) | 55 (34.8%) | |
Hypercapnia | 7 (5.4%) | 39 (13.3%) | 24 (8.3%) | 19 (7.2%) | 11 (4.1%) | 16 (10.1%) | |
Central nervous system | 24 (18.6%) | 47 (16%) | 40 (13.9%) | 32 (12.1%) | 45 (16.6%) | 19 (12%) | |
Peripheral nervous system | 0 (0%) | 1 (0.3%) | 2 (0.7%) | 4 (1.5%) | 5 (1.8%) | 2 (1.3%) | |
Trauma | 7 (5.4%) | 14 (4.8%) | 12 (4.2%) | 9 (3.4%) | 14 (5.2%) | 10 (6.3%) | |
Circulatory problem | 17 (13.2%) | 38 (13%) | 40 (17.4%) | 40 (15.1%) | 43 (15.9%) | 17 (10.8%) | |
Postoperative | 17 (13.2%) | 30 (10.2%) | 59 (20.5%) | 67 (25.2%) | 63 (23.2%) | 25 (15.8%) | |
Other | 7 (5.4%) | 13 (1.1%) | 16 (5.6%) | 11 (4.1%) | 10 (3.7%) | 14 (8.9%) |